Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The report forecasts strong growth in this sector over the next six years. The ADC market, composed of complex components including antibodies, conjugation chemistry, linkers, and payloads, is intensely competitive. Companies across the globe are continually innovating, improving drug performance and extending potential treatment for new types of cancers. Emerging technologies are striving to overcome current ADC technology drawbacks such as poor stability, which can lead to reduced efficacy, a narrow therapeutic index, and complex manufacturing processes.
Small and mid-sized enterprises leveraging Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) for initial drug development are generating novel therapeutic antibody technologies. In addition, many antibody developers are streamlining their in-house R&D while increasing their acquisitions or in-licensing of therapeutic antibody product lines to bolster their pipelines.
The report highlights that CDMOs are making substantial new investments to support the next generation of ADCs. Biopharmaceutical companies are increasingly focusing on ADCs to take advantage of target specificity for selective tumor antigens. Developers are also adopting robust strategies to improve the potency of payloads, as evidenced by the successful approval of seven ADCs over the past two years.
The report provides insights into key market trends, leading disruptors, and marketed and pipeline ADCs that will stimulate growth in both hematological and solid tumors. It also uncovers the growth opportunities emerging from this sector, which stakeholders can leverage.
Companies identified as ADC Market Disruptors in the report include Tubulis, LCB, Synaffix (Lonza), WuXi Biologics, Mersana Therapeutics, and Iksuda. These companies are praised for their broad spectrum of technology platforms, conjugation technology platforms, end-to-end ADC services, ADC CRDMO services, and late-stage ADC pipelines.
Key Topics Covered:
1. Strategic Imperatives
- The Impact of the Top 3 Strategic Imperatives on the ADC Industry
2. Growth Environment
- Scope of Analysis
- ADC Market Highlights
- Growth Opportunities: The ADC Market
- Growth Drivers
- Growth Restraints
- Drug Conjugates' History, Progress, and Research Stages
- ADC Market Trends
- ADC Technology Evolution
- Precision Oncology Approaches for ADCs
- Biomarker Application Across the Cancer Continuum
- Life Cycle Management Strategies
- ADC Deals and Investment Outlook
- Notable ADC Partnerships and Collaborations, 2022
- Notable ADC Partnerships and Collaborations, 2022 and 2023
- Approved ADCs: Hematological Cancer
- Approved ADCs: Solid Tumors
- Late-stage ADCs to Watch
3. Revenue Forecast and Analysis
- Forecast Assumptions
- Growth Metrics
- Revenue Forecast
- Revenue Forecast Analysis: Solid Tumors (Launched)
- Revenue Forecast Analysis: Solid Tumors (Pipeline)
- Revenue Forecast Analysis: Hematological Cancer (Launched)
- Revenue Forecast Analysis: Hematological Cancer (Late-stage Pipeline)
4. Companies to Action: ADC Market Disruptors
- Tubulis: Broad Spectrum of Technology Platforms
- LCB: Conjugation Technology Platforms
- Synaffix (Lonza): End-to-end ADC Services
- WuXi Biologics: ADC CRDMO
- Mersana Therapeutics: Late-stage ADC Pipeline and Platform
- Iksuda: A Toolbox Approach for ADC Development
5. Growth Opportunity Universe
- Growth Opportunity 1: ADC Combination Therapies for Precision Chemotherapeutics
- Growth Opportunity 2: Strategic Partnerships between CDMOs and Early-stage Platform and ADC Developers
- Growth Opportunity 3: Novel Linkers and Conjugation Chemistries
For more information about this report visit https://www.researchandmarkets.com/r/mesbqs
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
